Indonesia Singapore Malaysia Vietnam Thailand Philippines Myanmar

India Greater China Rest of Asia World

E-Commerce & Internet Economy Technology Real Estate and Infrastructure Financial Services Social Infrastructure Deals Barometer

China Digest: Xgene Pharmaceutical secures $40m; Biortus nets $30m

China Digest: Xgene Pharmaceutical secures $40m; Biortus nets $30m

Photo: Getty Images Pro via DealStreetAsia

05 November, 2021

Chinese drug developer Xgene Pharmaceutical Group and Wuxi Biortus Biosciences have secured funding.

Printed by Unregistered user on Tue, 26 Sep 2023 09:32:48 GMT

Wuxi Biortus Biosciences Xgene Pharmaceutical Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Related Stories

Venture Capital

China Digest: Newrizon, Transblock, XanPool raise funds

Newrizon raised $50m led by China Creation Ventures.

Venture Capital

China Digest: SIIF, Benlai launch industry funds; Yili to buy stake in Ausnutria

Benlai Group has set up a $78.2 million fund to invest in players in the fruit industry in north China.